The importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib from the perspective of dose intensity.

Author: ItoKoichi, KitagawaWataru, MasakiChie, NakataMisako, ShioyaJunko, SuginoKiminori, TerasawaYukiko, YokotsukaSatoshi

Paper Details 
Original Abstract of the Article :
Label="PURPOSE" NlmCategory="OBJECTIVE">Lenvatinib (LEN) is a multikinase inhibitor that strongly inhibits tyrosine kinase receptors, especially VEGFR-2, which can cause hypertension, as well as strong tumor shrinkage. Though control of any side effects (SEs) is important for maintaining dose intens...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00520-023-08163-x

データ提供:米国国立医学図書館(NLM)

Early Blood Pressure Control: Key to Maintaining Lenvatinib Dose Intensity

Lenvatinib is a powerful cancer treatment that can cause hypertension. This study investigates the importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib, focusing on how blood pressure control impacts the intensity of treatment.

The study found that blood pressure control within the first eight weeks of treatment with lenvatinib significantly affected the intensity of treatment during that period. This highlights the importance of early intervention and careful monitoring of blood pressure to optimize treatment effectiveness.

Early Blood Pressure Management: Crucial for Effective Cancer Treatment

This study suggests that early blood pressure management is crucial for ensuring optimal treatment outcomes in patients taking lenvatinib. By addressing hypertension early, we can potentially improve the effectiveness of lenvatinib treatment, ultimately leading to better cancer control.

Cancer Treatment: A Dance of Balancing Acts

Cancer treatment often involves managing a delicate balance between effectiveness and side effects. This study highlights the importance of proactively addressing potential side effects like hypertension to optimize treatment intensity and maximize its effectiveness. It's like walking a tightrope, ensuring we maintain a steady balance between treating the disease and managing its potential side effects.

Dr. Camel's Conclusion

Think of cancer treatment like a long journey across a vast and unpredictable desert. Early blood pressure control acts like a compass, helping us stay on course and navigate the challenges of treatment. This study reminds us that careful attention to details can make a big difference in the overall outcome of the journey. It's about finding that delicate balance between fighting the disease and taking care of the whole person.

Date :
  1. Date Completed 2023-11-30
  2. Date Revised 2023-11-30
Further Info :

Pubmed ID

38017341

DOI: Digital Object Identifier

10.1007/s00520-023-08163-x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.